Synthetic Biology: Recent Trends & Research

News and Trends 5 May 2017

Forget Chemical Synthesis, Yeast can Now Synthesize Complex Antibiotics

A new study presents a novel synthetic biology approach for antibiotic synthesis in yeast that could tackle the huge challenge of antibiotic resistance. Scientists at Imperial College London have hacked their way into introducing complex biosynthesis pathways in the baker’s yeast Saccharomyces cerevisiae. In particular, they focused on the production of non-ribosomal peptides (Nrp), a group of […]

May 5, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Interview 1 May 2017

This Founder is using Synbio to Revolutionize Genetic Medicine

Oxford Genetics founder and CEO Ryan Cawood told me about his company’s improvements to DNA design for better biologicals. Last month at Synbiobeta, I caught up with Ryan Cawood, who created one of the most successful synthetic biology companies around, Oxford Genetics. “Our direction actually took off from this conference,” he told me. “We saw […]

May 1, 2017 - 5 minutesmins - By Evelyn Warner

fungi secondary metabolites genome sequencing

News and Trends 21 Apr 2017

Fungi Genomes could be a Gold Mine of New Antibiotics

Good old Penicillium still has a lot more tricks upon its sleeve: Swedish researchers see its potential as a gold mine for new antibiotics. The genomic analysis of Penicillium species represents a potential gold mine for new bioactive compounds, or improved versions of those we already use. Published recently in Nature Microbiology, the work was carried at Chalmers University […]

April 21, 2017 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 10 Apr 2017

Swiss-Danish Collaboration will use Synbio to Produce a B Vitamin

Two startups in the fields of synthetic biology, Biosyntia and FGen, have struck a partnership to identify promising microbial strains. The objective is to find a strain that enables bioproduction of a B vitamin. The driving force of this new partnership between Biosyntia, Denmark, and ETH Zurich, and brands itself as a CRO for biologics […]

April 10, 2017 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 3 Apr 2017

New Results Show GM Mosquitoes Keep Dengue and Zika at Bay in Brazil

In its second year, Oxitec has reduced the mosquito population in a Brazilian neighborhood by 81%, demonstrating the long-term potential of GM insects. Oxitec is a spin-out from the University of Oxford that fights infectious disease with genetically-engineered mosquitoes that produce inviable offspring. The company has already made field trials in the Cayman Islands, Panama, Brazil, […]

April 3, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Interview 3 Apr 2017

Meet the Co-Founder who says DNA is the Next Silicon

DNA Script opens the door to a whole new age of manufacturing synthetic DNA. Thomas Ybert, was only 30 when he co-founded the company – here’s his story! Based in Paris, DNA Script produces synthetic DNA using a proprietary template-free enzymatic technology. Most of the manufactured DNA is currently synthesized by chemical means, but this startup […]

April 3, 2017 - 5 minutesmins - By External Contributor

News and Trends 31 Mar 2017

French Synbio Company gets ready to break into Cosmetics

After biofuels and carotenoids, Deinove is now moving forward on the cosmetics front. Its engineered microbes can produce a number of interesting chemicals for skin care, and Deinove plans to bring them to market until the end of 2018. Deinove is a key synbio biotech in France and has found a wide range of applications for […]

March 31, 2017 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 14 Mar 2017

Huge Successful €103M IPO for the Next European Leader in Bioplastics

Avantium has gone public and raised €103M on Euronext Amsterdam and Euronext Bruxelles with Sofinnova Partner as the main shareholder. Avantium, a spin-off from Shell, is developing renewable bioplastics made 100% from plant-based materials with the support of big partners such as Coca-Cola or Danone, for which the Dutch biotech is developing sustainable PlantBottles and yogurt cups, […]

March 14, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 10 Mar 2017

SynBio Success with Enzyme opens Jet Fuel Production Possibilities

The well-known but stubborn FAS enzyme has been successfully modified to make petrol and jet fuel. This research opens up possibilities to produce biofuels with engineered microorganisms, or “cell factories”. Researchers from Chalmers University of Technology in Sweden have developed a method to modify the enzyme fatty acid synthase (FAS). This complex enzyme has long been […]

March 10, 2017 - 2 minutesmins - By Denise Neves Gameiro

electronic plants e plants bioelectronics Linköping

More News! 3 Mar 2017

Plants go Electronic with new Swedish Magic Sauce

e-Plants can become a reality with a new technique that creates in vivo electronic circuits. But what are these bioelectronic plants for? A research team from the Linköping University has developed a ‘magic sauce’ that can transform the normal vascular system, through which they transport water and nutrients from the roots, into an electronic circuit. […]

March 3, 2017 - 3 minutesmins - By Denise Neves Gameiro

Isogenica Maverick Therapeutics llama antibodies cancer 1

News and Trends 7 Feb 2017

British Synbio’s Llama Antibodies recruited for Cancer T-Cell Therapy

Isogenica has licensed its synthetic llama antibody library to Maverick Therapeutics, which develops cancer T-cell therapies designed to reduce side effects. Isogenica is a synthetic biology company near Cambridge that develops libraries of therapeutic antibodies. The biotech has granted US-based Maverick Therapeutics licenses to its llamdA VHH antibody library for the discovery, development and commercialization of […]

February 7, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 25 Jan 2017

Cryopreservation: Can you Cheat Death by Freezing Yourself?

Some people have already decided to take a leap of faith by cryogenically freezing themselves, often in the attempt to beat a yet incurable disease. Is science ready for it? And are we? Cryopreservation is a fairly common practice in sci-fi cinema. Several film directors – from Stanley Kubrick in his masterpiece “2001: A Space […]

January 25, 2017 - 4 minutesmins - By External Contributor

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us